Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q3 2017 · 10-Q
Revenue$6.83B$6.83B+28.8% vs Q3 2016 Net Income$603.00M$603.00MN/M vs Q3 2016 EPS Diluted$0.34$0.34N/M vs Q3 2016 Gross Profit$3,452,000,000+20.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,005,000,000+64.7% Free Cash Flowderived$1,742,000,000+92.5% Margins · derivedGross margin50.5%−3.7 pt vs Q3 2016
Operating margin11.3%−5.7 pt vs Q3 2016
Net margin8.8%+15.0 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 2, 2017 · 33 d after period end